Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2004 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

3 results
Results by year
Filters applied: . Clear all
Page 1
Clinical practice. Latent tuberculosis infection.
Jasmer RM, Nahid P, Hopewell PC. Jasmer RM, et al. N Engl J Med. 2002 Dec 5;347(23):1860-6. doi: 10.1056/NEJMcp021045. N Engl J Med. 2002. PMID: 12466511 Review. No abstract available.
Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: a multicenter clinical trial.
Jasmer RM, Saukkonen JJ, Blumberg HM, Daley CL, Bernardo J, Vittinghoff E, King MD, Kawamura LM, Hopewell PC; Short-Course Rifampin and Pyrazinamide for Tuberculosis Infection (SCRIPT) Study Investigators. Jasmer RM, et al. Ann Intern Med. 2002 Oct 15;137(8):640-7. doi: 10.7326/0003-4819-137-8-200210150-00007. Ann Intern Med. 2002. PMID: 12379063 Clinical Trial.
Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: a cost-effectiveness analysis based on a multicenter clinical trial.
Jasmer RM, Snyder DC, Saukkonen JJ, Hopewell PC, Bernardo J, King MD, Kawamura LM, Daley CL; Short-Course Rifampin and Pyrazinamide for Tuberculosis Infection Study Investigators. Jasmer RM, et al. Clin Infect Dis. 2004 Feb 1;38(3):363-9. doi: 10.1086/380966. Epub 2004 Jan 13. Clin Infect Dis. 2004. PMID: 14727206 Clinical Trial.